Cite
Life-threatening complications and intensive care unit management in patients treated with blinatumomab for B-cell acute lymphoblastic leukemia.
MLA
Urbino, Irene, et al. “Life-Threatening Complications and Intensive Care Unit Management in Patients Treated with Blinatumomab for B-Cell Acute Lymphoblastic Leukemia.” Critical Care (London, England), vol. 28, no. 1, Jan. 2024, p. 14. EBSCOhost, https://doi.org/10.1186/s13054-023-04787-x.
APA
Urbino, I., Lengliné, E., Valade, S., Cerrano, M., Sebert, M., Raffoux, E., Rabian, F., Azoulay, E., & Boissel, N. (2024). Life-threatening complications and intensive care unit management in patients treated with blinatumomab for B-cell acute lymphoblastic leukemia. Critical Care (London, England), 28(1), 14. https://doi.org/10.1186/s13054-023-04787-x
Chicago
Urbino, Irene, Etienne Lengliné, Sandrine Valade, Marco Cerrano, Marie Sebert, Emmanuel Raffoux, Florence Rabian, Elie Azoulay, and Nicolas Boissel. 2024. “Life-Threatening Complications and Intensive Care Unit Management in Patients Treated with Blinatumomab for B-Cell Acute Lymphoblastic Leukemia.” Critical Care (London, England) 28 (1): 14. doi:10.1186/s13054-023-04787-x.